bvs-20220712
0001665988FALSE00016659882022-07-122022-07-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 12, 2022
 
Bioventus Inc.
(Exact name of registrant as specified in charter)